Select Medical's acquisition waiting period ends; merger with WCAS-led consortium expected mid-2026.

Select Medical Holdings announced the expiration of the Hart-Scott-Rodino antitrust waiting period for its acquisition by a WCAS XIV, L.P. subsidiary and a consortium led by Select Medical executives. The merger is anticipated to close by mid-2026, pending shareholder approval and customary closing conditions. This acquisition could impact Select Medical's operations, which include critical illness recovery and rehabilitation hospitals across the U.S. The company and investors await further regulatory and shareholder decisions before finalizing the deal.